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ABSTRACT
Hypoglycemia is a significant complication of intensive diabetes therapy, a true medical emergency, 
which requires prompt recognition and treatment to prevent organ and brain damage. Therefore, knowl-
edge about diabetes can play an important role in maintaining glycemia control and prevent hypogly-
cemic complications.
Aim: The aim of the study is to develop and assess the impact of patient information leaflets to prevent 
hypoglycemia in outpatients with type 2 diabetes mellitus and to study the effect of prescribed drugs 
pattern in patients.
Material & Methods: This open labelled, interventional study was conducted in the endocrinology Out 
Patient Department (OPD) in a tertiary care hospital over a period of 9 months in 55 patients. The infor-
mation was provided to patients through a developed patient information leaflet and their awareness 
and glycemic status were assessed by an internally institution developed vernacular language based 
validated questionnaire. The questionnaire with four different dimensions patient knowledge, glycemic 
control, compliance and life style was quantified in the study.
Results: The study showed statistically significant (P<0.05) improvement in knowledge and glycemic 
control in male patients and in knowledge, compliance, and glycemic control for female patients. Liter-
ate patients showed more significant improvement in knowledge, compliance, life style, and glycemic 
control than illiterate patients.
Conclusions: Results of the study suggested that pharmacist provided patient education and awareness 
helped type 2 diabetic hypoglycemic patients to improve knowledge and glycaemic control.
Keywords: Diabetes; Hypoglycemia; Patient Education; Consumer health information leaflets
RESUMEN
La hipoglucemia es una complicación importante de la terapia intensiva de la diabetes, una verdadera 
emergencia médica, que requiere un reconocimiento y tratamiento rápidos para prevenir el daño cere-
bral y de órganos. Por lo tanto, el conocimiento sobre la diabetes puede desempeñar un papel importante 
en el mantenimiento del control de la glucemia y prevenir las complicaciones hipoglucémicas.
Objetivo: el objetivo del estudio es desarrollar y evaluar el impacto de los folletos de información al 
paciente para prevenir la hipoglucemia en pacientes ambulatorios con diabetes mellitus tipo 2 y estudiar 
el efecto del patrón de medicamentos recetados en los pacientes.
Material y métodos: Este estudio abierto de intervención abierta se realizó en el Departamento de pa-
cientes ambulatorios (OPD) de endocrinología en un hospital de atención terciaria durante un período 
de 9 meses en 55 pacientes. La información se proporcionó a los pacientes a través de un folleto de 
información al paciente y su conocimiento y estado glucémico se evaluaron mediante un cuestionario 
validado basado en el lenguaje vernáculo desarrollado internamente en una institución. El cuestionario 
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con cuatro dimensiones diferentes de conocimiento del paciente, 
control glucémico, cumplimiento y estilo de vida se cuantificó en 
el estudio.
Resultados: El estudio mostró una mejora, estadísticamente sig-
nificativa (P <0,05), en el conocimiento y el control glucémico en 
pacientes masculinos y en el conocimiento, el cumplimiento y el 
control glucémico en pacientes femeninos. Los pacientes alfabeti-
zados mostraron una mejora más significativa en el conocimiento, 
el cumplimiento, el estilo de vida y el control glucémico que los 
pacientes analfabetos. Conclusiones: Los resultados del estudio 
sugirieron que el farmacéutico brindó a los pacientes con hipoglu-
cemia diabética tipo 2 información y conciencia para mejorar el 
conocimiento y el control glucémico.
Palabras clave: Diabetes; hipoglucemia; Educación del paciente; 
Folletos de información de salud para el consumidor
INTRODUCTION
Hypoglycemia is a condition featuring lower than normal 
levels of blood glucose. It can be defined as “mild” if ep-
isode is self-treated; “moderate” if assisted, and “severe” 
if hospitalised and assisted by physician (Diabetes Con-
trol and Complications Trial, 1993). Hypoglycemia could 
be classified as a true medical emergency, which left un-
treated may lead to organ and brain damage1. It is a sig-
nificant complication of intensive diabetes therapy. Severe 
untreated hypoglycemia can cause significant economic 
and personal burden. Hence, identification and prevention 
of hypoglycemia are very important factors for prevention 
of hypoglycemic complications2. Diabetic medications, 
including insulin and sulfonylureas, are among the most 
common causes of hypoglycemia in diabetic subjects3. Oc-
casional episodes of hypoglycemia with metformin are re-
ported when an imbalance between food intake and dose of 
metformin2. According to Diabetes Audit and Research in 
Tayside Scotland (DARTS) study, severe hypoglycemia was 
observed in 7.3% and 0.8% of patients with Type 2 Diabetes 
Mellitus (T2DM) treated with insulin and oral sulfonylurea 
respectively. The risk of hypoglycemia is highest in those 
with T2DM, who have received insulin for more than 10 
years4. T2DM patients lose, on an average, three productive 
days following a severe hypoglycemic attack. The Action 
to Control Cardiovascular Risk in Diabetes (ACCORD) Tri-
al has demonstrated increased mortality rates in patients 
who experienced episodes of hypoglycemia. Repeated 
episodes of hypoglycemia can result significant mortality 
which is reportedly associated with a six fold increase in 
death. The clinical approach to minimize hypoglycemia 
while improving glycemic control includes addressing the 
issue, applying the principles of aggressive glycemic ther-
apy, including flexible and individualized drug regimens, 
and considering the risk factors for iatrogenic hypoglyce-
mia5. Main measures to prevent hypoglycemia includes 
drug counselling, meal plan, limiting the use of alcoholic 
beverages, and through appropriate diabetes management 
plan. The knowledge and education can also help patients 
to manage their glycemic conditions effectively along with 
pharmacological management6-12. Many health profession-
als rely on a verbal explanation, but this has been shown to 
be ineffective; patients tend to forget approximately half of 
the given information13. One method of providing informa-
tion is to supply a patient information leaflet. It have also 
been shown to increase knowledge of drug side effects in 
a series of studies undertaken in the community14-15. The 
present study was undertaken to develop a patient infor-
mation leaflet and evaluate the impact of it in education 
by pharmacist with respect to knowledge, compliance, life 
style, and glycemic control in T2DM patients with hypo-
glycemia. The effect of prescribed drugs pattern for the 
management of glycemic control in patients will also be 
investigated.
MATERIALS AND METHODS
Study design
The open labelled, interventional study was conducted in 
the endocrinology outpatient department in a tertiary care 
hospital for a period of 9 months from June 2015 to Feb-
ruary 2016 . Institutional Ethics Committee (IEC) approval 
was taken before initiation of the study.
Sample size calculation
Sample size was calculated as 55 based on the outpatient 
statistics of endocrinology department. Raosoft sample 
size calculator with margin of error 5%, confidence level 
95%, and probability was used for calculation. A total of 
385 diabetic patients were screened out of which 100 hypo-
glycemic patients were identified. Fifty five patients were 
included in the study based on the inclusion and exclusion 
criteria.
Inclusion and exclusion criteria
Both male and female hypoglycemic patients of age >18 
years diagnosed with T2DM were included. Patients on 
Oral Hypoglycemic Agents (OHA’s) and/or insulin were 
included in the study. Pregnancy, lactation, psychosis, men-
tal retardation, active substance abuse, and significant de-
pression patients were excluded from the study. Patients 
who were not willing to provide consent were excluded 
from the study.
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Patient Information leaflet development
Before the main study, a preliminary study was carried out 
with 10 consecutive hypoglycemic literate and illiterate pa-
tients who were attending the outpatient clinic. First step 
of the study was patient interaction, which helped us iden-
tifying various barriers such as poor knowledge about the 
condition, lack of compliance towards treatment, lifestyle, 
and poor medication adherence. After assessing the bar-
riers, a questionnaire was prepared based on diabetic pa-
tients perception about hypoglycemia and its management. 
The institution developed questionnaire in vernacular lan-
guage was validated by two expert endocrinologists in the 
study site. The questionnaire was an effective tool to iden-
tify patient problems in order to give an effective educa-
tion. The questionnaire cited (Table 1) includes 20 questions 
under 4 different categories like knowledge (9 questions), 
compliance (5 questions), life style (3 questions), and glyce-
mic control (3 questions) , which was tested in preliminary 
study 2 in 10 literate and illiterate patients. None experi-
enced problems with its readability in vernacular language 
and the patients thought that the patient information leaflet 
based on the 20 questionnaire, answered the queries they 
would raise about hypoglycemia and it’s management. 
Based on this, a comprehensive patient information leaflet 
was prepared. A data collection form was also designed 
to record laboratory values, including blood glucose level 
and other patient specific details. Informed consent from all 
patients was collected before participation, briefing them 
about the study in colloquial language.
Table 1: Hypoglycemia Questionnaire
Parameter Questions
Knowledge
Do you know what diabetes is?
a) It is an abnormal increase in blood glucose levels in human body.
2) Do you know what the types of diabetes are?
Increase in blood glucose due to absence of insulin producing cells.
Increase in blood glucose because the cells doesn’t take up the insulin.
Increase in blood glucose during pregnancy.
Increase in blood glucose due to other reasons.
3) Do you know what hypoglycemia is?
a) It is an abnormal lowering in blood glucose levels in human body.
4) Do you know what HBA1c is?
a) It is the average level of blood glucose.
5) Do you know what the symptoms of hypoglycemia are?
a) Headache
b) Feel shaky
c) Sweating
d) Feel hungry
e) Rapid heart beat
f) Drowsiness
g) Difficulty in talking
h) Blurred vision
i) Double vision
6) Is diabetes a hereditary disease? (Yes/No)
7) Do you regularly take your medications as advised by the doctor? (Yes/No)
8) Do you know what insulin is?
a) Insulin is a key that opens the cells to take up glucose.
9) Do you have a glucometer? Do you know how to use it?
(Yes/No)
Compliance
1) How often do you check your blood glucose?
a) Once in a month or whenever sugar level is to be checked.
2) How often do you check your HBA1c values?
a) 1 to 3 months.
3) What precautions do you take to prevent or treat hypoglycemic episode?
a) Keep candy or chocolate.
b) Check your blood glucose level regularly
4) Do you know how to treat hypoglycemia immediately?
a) 2 to 3 spoon of glucose powder
b) Half cup of any fruit juice
c) 5 or 6 piece of hard candy
d) One tablespoon of sugar
5) What have you done to prevent further episodes of hypoglycemia?
a) Reducing the dose of insulin
b) Reducing the dose of tablets
c) Eating more food(rich in carbohydrate)
8 Ars Pharm. 2019; 60(1): 5-14
Sankar V, et al.
Life style
1) At what time of the day there is high risk of hypoglycemic episode?
a) Night
2) Do you exercise regularly? (Yes/No)
3) Have you ever met a dietician for dietary counseling regarding diabetes mellitus? (Yes/No)
Glycemic 
control
1) What are the normal blood glucose levels?
a) FBS<100
b) RBS>100
c) PPBS<140
2) Do you know, below which level the hypoglycemia is happening?
a) Below 70 mg/dL
3) Is there any improvement in your blood glucose than the previous blood glucose levels?   (Yes/No)
Method of assessment
Patient information leaflet (Table 2) was given to the patient 
and the questionnaire was read out to them. Marks were 
recorded based on the answering pattern after their enrol-
ment in the start of the study (baseline) and during revisit 
at sixty days interval (final). Scoring of marks was done at 
the baseline and in final based on 1 for Yes and 0 for No. 
The assessment was done based on the patient question-
naire marks and glycemic status. The quantitative variables 
related to glycemic status like Fasting Blood Sugar (FBS) 
and Post Prandial Blood Sugar (PPBS) and the other param-
eters related to patient information leaflet like knowledge, 
compliance, lifestyle and glycemic control were recorded. 
The changes in the variables and parameters before and af-
ter the patient information leaflet education were recorded
Table 2: Patient Information Leaflet
HYPOGLYCEMIA:
Hypoglycemia or hypo, is the lowering of blood glucose 
level below 70 mg/dL.This is too low to provide sufficient 
energy for your body activities. Hypoglycemia can happen 
when you are treated with insulin or certain diabetes med-
ication. No matter how much you know about diabetes or 
how careful you are, if your diabetes is treated with certain 
medication, you are likely to experience some hypoglyce-
mia. Leaflet is designed to give you information to prevent, 
recognize and treat hypoglycemia.
SYMPTOMS:
 – Sweating
 – Hungry
 – Tingling
 – Tremor
 – Heart pounding
 – Difficulty in speaking
 – warm
 – weak
 – confused
 – Tired/drowsy
 – Faint/dizzy.
CAUSES:
 – Too much insulin/too many tablets.
 – Delayed or missed meal or snack.
 – Not enough food, especially carbohydrate.
 – Unplanned or strenuous activity.
 – Drinking too much alcohol or alcohol without food.
IMMEDIATE TREATMENT:
 – 2 to 3 spoons glucose powder.
 – Half cup of any fruit juice
 – Half cup of a regular soft drink
 – 5or 6 piece of hard candy
 – 1 table spoon of sugar, if anyone
FOLLOW ON TREATMENT:
 – To prevent the blood glucose dropping again, you 
should follow your sugary foods with a starchy carbo-
hydrate snack.eg: a sandwich, fruit, a bowl of cereal, bis-
cuits and milk, the next meal if it’s due.
MANAGEMENT OF HYPOS AT NIGHT:
 – Check your blood glucose between 2 am and 3 am when 
hypos are most likely to happen.
 – Keep something sugary by your bed.
 – Alternatively have a bed-time snack such as biscuits and 
milk, sandwich, fruit or yogurt.
HYPOS AND PHYSICAL ACTIVITY:
Physical activity lowers your blood glucose level, so it is 
important to eat some form of carbohydrate before hand, 
and possibly during and after your activity if it is strenuous 
or lasts a long time. Hypos can happen up to 36 hours after 
strenuous or prolonged physical activity so you might need 
to adjust your medication or carbohydrate intake.
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HYPOS AND DRIVING:
Always test your blood glucose levels before driving. If you 
feel you may be experiencing a hypo, pull over, stop the car 
and remove the keys from the ignition.
HYPOS AND ALCOHOL:
During a lot alcohol or drinking on an empty stomach 
makes a hypo more likely. The signs of a hypo are also very 
similar to those of being drunk. Always have something to 
eat if you are drinking alcohol, and tell the people you are 
with about your diabetes and what to do if you need help 
treating a hypo.
IMPORTANT POINTS TO REMEMBER:
 – Always have something sugary with you for use in an 
emergency.
 – Always carry/wear some form of identification specify-
ing you have diabetes and your treatment.
Tell your friends, relatives and colleagues that you have di-
abetes and let them know how to help if you have a hypo.
Statistical analysis
Data was statically analysed using student’s t test (graph 
pad prism version 5). Statistical significance was taken at 
95% CI (p<0.05) using SPSS 16 version. The multivariable 
studied and analyzed were knowledge, compliance and 
lifestyle, and glycemic control. P values<0.05 were accepted 
as statistically significant
Ethics
This study was in accordance with the Ethics Committee 
of the institution (protocol no: 14/272). Permission was 
taken from the hospital administrators. After revealing the 
aim and duration of the study to the participants, the par-
ticipants were announced that they could leave the study 
whenever they wanted. Written informed consent was pro-
vided from all the participants/Care takers.
RESULTS
Out of 55 patients included in the study, 26 patients had a 
family history of T2DM. Regarding the literacy of patients, 
47 (85.45%) patients were literate, 8 (14.54%) patients were 
illiterate. Patients who did not complete high school educa-
tion were categorised as illiterate persons. Among the sub-
jects, 17 (30.90%) were alcoholic, 20 (36.36%) were smokers.
Hypoglycemic episodes were more prevalent in the age 
group of 50-59 years in both male and female patients fol-
lowed by the age group of 60-69 years (Table 3). Hyperten-
sion and dyslipidemia were the co morbidities in the study 
subjects and the other co morbidities are shown in Figure 1.
Figure 1: Co morbidities in the study subjects
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Patients were on antihypertensive and dyslipedmic drugs 
in addition to drugs controlling diabetes. The treatment as-
pects of the male and female patients are shown in (Table 
3). Combinations of drugs were observed in the diabetic 
treatment schedule, which may delay the need for insulin 
or in combination with insulin aid in achieving glycemic 
goals.
Table 3: Multivariate analysis of dependent variables
Source Dependent Variable
Type III sum of 
squares
Degree of 
freedom
Mean square Distribution Significance
Education Knowledge 437.527 1 437.527 133.270 0.000
Compliance 170.909 1 170.909 34.573 0.000
Lifestyle 109.382 1 109.382 22.127 0.000
Glycemic control 553.745 1 553.745 156.109 0.000
Gender Knowledge 0.000 1 0.000 0.000 1.000
Compliance 7.969 1 7.969 2.988 0.090
Lifestyle 13.015 1 13.015 1.753 0.191
Glycemic control 17.169 1 17.169 7.428 0.009
Age Drugs 12.363 5 2.473 0.985 0.438
Changes in fasting 
blood sugar
866.320 5 173.264 4.288 0.003
Gender Drugs 2.390 1 2.390 .952 0.334
Changes in fasting 
blood sugar
128.267 1 128.267 3.174 0.082
Patients treated with sulfonylurea along with biguanides 
(n=6) the fasting blood sugar level was less and closer to 70 
mg/dl hence the hypoglycaemic chances are more (Table 
4).
Table 4: Effect of anti-diabetic therapy on glycemic status in hypoglycemic patients
Age
(years)
Male 
(N)
Female 
(N)
Percent-
age (%)
No. of
pa-
tients
Anti-diabetic therapy 
regimens
FBS mg/
dl
PPBS mg/
dl
Baseline
ME±SD
Final
ME±SD
Baseline
ME±SD
Final
ME±SD
20-29 1 2 10.84 1 SOHA (B and AGI) 68 90 120 132
1 COHA (S+B) 68 66 99 95
1 SOHA (B) 65 78 93 103
30-39 0 4 14.28 3 SOHA (B) 72 ±1.41 81.5±4.9 96 ± 4.85 114±2.8
1 SOHA (B and fI) 69 84 92 110
40-49 3 7 36.11 1 COHA (S+B) 68 65 90 99
4 SOHA(B) 142.6 ±5.9 155.6±1.2 215.6±7 230.6±3.50
1
SOHA&COHA
( B) (S+ B)
69 67 96 103
4 SOHA and I (B and I) 142.3 ±1.5 157.5±2.4 198.6±1.5 229.3 ±0.3
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50-59 11 9 72.88 2 COHA (S + B) 67 67 99 97.5
6 SOHA(B) 149±8.04 167.7±3.9 207.5±5.1 228±8.14
10 SOHA and I (B and I) 147.6±6.7 180.12±8.9 214.2±7.5 227.2±5.83
2 SOHA(AGI)and I 64 80.5 92.5 113.5
60- 69 9 5 51.18 3 COHA (S + B) 71.3±5.6 70.6±6.6 99.6±15.3 108.3±18.9
2 SOHA (B) 136 150 177 206
7 SOHA& I (B & I) 142.6±2.8 160±5.2 191.3±8.5 198.3±7.8
2 COHA& I (S+B& I) 64 80.5 92.5 113.50
70-79 3 1 14.68 2 COHA(S+ B) 69 65.50 87.5± 89.50
1 SOHA(B) and I 71 73 90 103
1
SOHA&COHA (B) 
(S + B)
62 65 84 90
SOHA- Single Oral Hypoglycemic Agent, AGI – Alpha glucosidase Inhibitors, COHA- Combination Oral Hypoglycemic Agent, S- Sul-
fonyurea, B- Biguanide, I-Insulin, FBS: Fasting blood sugar, PPBS: Post Prandial Blood Sugar, Combination of Single Oral Hypoglycemic 
Agent and Combination Oral Hypoglycemic Agent, N Number , Mean ± SD average value of determinations.
The baseline and final value of knowledge status were 
10.86±6.01 and 21±4.39 respectively with a value (p<0.001). 
The baseline and final value of glycemic control were 9±7.89 
and 17.17± 6.79 with a value (p<0.009) (Table 5).
Table 5: Effect of patient information leaflet education by pharmacist in hypoglycemic patients
Parameter
Baseline Final p value
Male
ME±SD
Female 
ME±SD
Literate 
ME±SD
Illiterate 
ME±SD
Male
ME±SD
Female 
ME±SD
Literate 
ME±SD
Illiterate 
ME±SD
Male
Fe-
male
Liter-
ate
Illiter-
ate
Knowledge 10.86±6.01 12.14±7.10 32±7.25 2.43±0.97 21±4.39 21.71±5.93 39.86±5.81 2.86±1.34 0.001* 0.004* 0.01* 0.07
Compliance 15±8.18 16.33±6.42 36±6.24 2.67±0.57 21.67±4.04 22.33±5.50 41±4.58 3.33±0.57 0.12 0.02* 0.03* 0.18
Life style 11.50±8.85 14.50±9.46 30.25±5.5 2±0.81 21±4.69 23±6.68 34.75±5.62 2.50±1.29 0.08 0.10 0.061* 0.182
Glycaemic 
control
9±7.89 9.17±9.62 29.17±9.62 2.33±0.81 17.17±6.79 18.33±7.36 39.33±6.47 2.83±1.16 0.009* 0.01* 0.029* 0.076
*paired t-test indicating significance. Mean ± SD average value of determinations
Literate study subjects showed significant improvement in 
knowledge, compliance, and glycemic control after convey-
ing the relevant information through patient information 
leaflets. The baseline and final value of knowledge status 
were 32±7.25 and 39.86±5.81, respectively, with a value 
(p<0.01). The baseline and final value of compliance were 
36±6.24 and 4±4.58, respectively, with a value (p<0.03). The 
base line and final value of glycemic control were 29.17±9.62 
and 39.33±6.47, respectively, with a value (p<0.02) as de-
picted in (Table 5).
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DISCUSSION
Hypoglycemic findings with respect to age group are sim-
ilar to the observations by the Decoda study group stating 
that the prevalence was over 30% among those aged 50-69 
years17.
The advantage of differing mechanisms of action, in com-
bination therapy as a mean of optimizing glycemic control 
was also observed in the treatment pattern. In multivari-
ate analysis, age and gender does not associate with pre-
scribing practice of anti-diabetic drugs ( Table 3). Patients 
receiving combination oral hypoglycemic agents (n=6), 
sulfonylureas (Gliclazide or Glimepride) along with bigua-
nides experienced more hypoglycemic episodes than those 
on biguanides alone (n=16).
Multivariate analysis confirmed age (p<0.01) have an effect 
on hypoglycemic states of patients (Table 3). But gender 
doesn’t affect the hypoglycemic states. In the age group 
30-39, 40-49, and 50-59 treated with biguanides alone have 
shown both FBS and PPBS high. Similarly treatment with 
biguanides and insulin combination in the age group 
showed statistically significant (p<0.05) higher level fasting 
blood sugar level after treatment in the age group (n=21) 
of 40-49, 50 – 59 and 60-69 years. Hence the hypoglyce-
mic chances are less (Table 4). At the same time we have 
also also observed that combination of oral hypoglycemic 
agents (sulphonamides and biguanides) in the age group 
50-59, 60-69, 70-79 showed less FBS level but increased 
PPBS level.
The study results also confirm that biguanides and insu-
lin medication combination maintains fasting blood sugar 
without hyplglycemia when compared to sulphonyl area 
with biguanides. Post Prandial Blood Sugar (PPBS) level re-
mains more than 84 mg/dl in all groups with respect to the 
baseline and final values after treatment (Table 4).
As expected at the onset of the study, both male and fe-
male patients knew little about hypoglycemia and this 
was noted through the baseline score. In this study, there 
was a considerable improvement in all parameters of hy-
poglycemic awareness status in male and female patients. 
Patient knowledge, compliance and lifestyle factor has not 
been affected by means of gender, but it significantly affects 
glycemic control (p<0.01) in multivariate analysis. Concur-
rently, education (p<0.0001) have significantly influence on 
patient knowledge, compliance and lifestyle factor as well 
as glycemic control ( Table 3).
The literacy have significantly influenced on patient knowl-
edge, compliance, lifestyle factor as well as glycemic con-
trol compared to illiterates. Illiterate showed improvement 
in knowledge, compliance, life style, and glycemic control 
(Table 5), the level of significance is not perceptible in any 
of the parameters and this may be due to the small sample 
size of patients enrolled in the study. This also indirectly 
confirms that the developed patient information leaflet was 
concise at readable level, in more easily understood format 
and increased patient knowledge about hypoglycemia.
This information empowers literate patients to become 
more involved in the decision making and hypoglycemia 
management process. Paulose carried out disease aware-
ness study in 400 literate diabetic patients in kerala. The 
study found that although 80% of patients knew the symp-
toms of hypoglycemia and 76% knew what to do when they 
develop these symptoms, only 17% carried glucose packets 
with them during travel and 29% patients told that their 
doctors did not inform them about hypoglycemic compli-
cations17. These studies suggest that it is essential to edu-
cate the patients regarding proper diet, exercise, glucose 
control, and periodic consultations 1, 6, 11, 18.
Our study results also showed the impact of pharmacist 
education in the significant improvement about diabetes 
knowledge, compliance, and glycemic control in hypogly-
cemic patients. Patient involvement is essential for success-
ful management of hypoglycemia Educational efforts are 
also necessary to improve self-management of hypoglyce-
mia in diabetic patients. Along with other health care pro-
fessionals, role of pharmacist as diabetic counsellor is much 
appreciated in many developed countries.
Although improving patients knowledge on hypoglycemia 
through patient information leaflet is a laudable aim, it is 
acknowledged that knowing and understanding are differ-
ent entities and consequently it cannot be assumed from 
the results of this study.
The effect of antidiabetic therapy on glycemic status with 
respect to different age group and duration of diabetes 
was not determined due to the small sample size among 
the groups. Further long duration studies covering a large 
population are needed to validate the data.
CONCLUSION
Our study confirms the patient´s knowledge and glycaemic 
control in out-patients with type 2 diabetes mellitus with 
hypoglycemia can be overcome through the development 
of patient information leaflet and education by a pharma-
cist. The study confirmed the impact in the knowledge 
about diabetes, compliance, and glycemic control in hypo-
glycemic patients significantly (p<0.05). Treatment pattern 
highlights hypoglycemic risk is less in most age groups 
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treated with biguanides alone and biguanides with insulin 
compared to sulphonylureas with biguanides
REFERENCES
1. Akkineni S, Mathews AM, Apuroopa G, Sridhar N.N. A study 
on patients awareness, recognition management and preva-
lence of hypoglycemic episodes in type 2 diabetes mellitus 
in a tertiary care hospital. Asian J Pharm Clin Res. 2015; (8): 
390-394.
2. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani M. The 
importance of hypoglycemia in diabetic patients. J Diabetes 
Metab Disord. 2012; 11:186-191. doi: 10.1186/2251-6581-11-17.
3. Martin G. Hypoglycemia risk with oral anti-diabetic drugs. 
Diabetic Hypoglycemia. 2009;1(3):17-18.
4. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: 
pathophysiology, frequency, and effects of different treat-
ment modalities. Diabetes care. 2005;28(12): 2948-2961. doi.
org/10.2337/diacare.28.12.2948.
5. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. 
Diabetes Care. 2003;26(6):1902-1912. doi.org/10.2337/dia-
care.26.6.1902.
6. Colin Tidy. Patient Access: Diabetes Education and Self-man-
agement Programmes. [Internet]. [Cited December 02, 2016].
Available from: http://patient.info/doctor/diabetes-educa-
tion-and-self-management-programmes.
7. Harvey JN. Psychosocial interventions for the diabetic patient. 
Diabetes Metab Syndr Obes. 2015;(8):29-43. doi: 10.2147/
DMSO.S44352.
8. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycemia 
in type 2 diabetes. Diabet Med. 2008;25(3):245-254. doi: 
10.1111/j.1464-5491.2007.02341.x.
9. Gravelling AJ, Frier BM. Impaired Awareness of Hypoglyce-
mia: a review. Diabetes Metab. 2010;(36): 64-74. doi:10.1016/
S1262-3636(10)70470-5.
10. Signorovitch JE, Macaulay D, Diener M, Yan Y, Wu EQ, Gru-
enberger JB, et al. Hypoglycemia and accident risk in people 
with type 2 diabetes mellitus treated with non-insulin anti-
diabetes drugs. Diabetes Obes Metab. 2013;15(4): 335–341. 
doi:10.1111/dom.12031.
11. Berhe KK, Gebru HB, Kahsay HB, Kahsay AA. Assessment 
of diabetes knowledge and its associated factors among type 
2 diabetic patients in Mekelle and Ayder Referral Hospitals. 
Ethiopia J Diabetes Metab. 2014;171(57):3. doi: 10.4172/2155-
6156.1000378.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive 
blood glucose control with sulfonylureas or insulin compared 
with conventional treatment and risk of complications in pa-
tients with type 2 diabetes (UKPDS 33). Lancet. 1998; (352): 
837-853. doi.org/10.1016/S0140-6736(98)07019-6.
13. Ley P. Satisfaction, compliance and communication. Br J Clin 
Psychol. 1982;2(4)1: 241- 254. doi.org/10.1111/j.2044-8260.1982.
tb00562.x.
14. Gibbs S, Waters WE, George CF. The benefits of prescription 
information leaflets (1). Br J Clin Pharmacol. 1989;27(6): 273-
339.
15. Gibbs S, Waters WE, George CF. The benefits of prescription 
information leaflets (2). Br J Clin Pharmacol.1989;28(3): 345-
351.
16. The DECODA Study Group. Age and sex specific prevalence 
of diabetes and impaired glucose regulation in 11 Asian co-
horts. Diabetes Care 2003;26(6): 1770-1780. doi.org/10.2337/
diacare.26.6.1770.
17. Paulose KP. Disease awareness study in diabetic patients. 
Asian J Diabetol, 2000;2: 5-19.
18. Adepu R, Swami M K. Development and Evaluation of patient 
information leaflets. 2012;74(2): 174-178. doi: 10.4103/0250-
474X.103857.
14 Ars Pharm. 2019; 60(1): 5-14
Sankar V, et al.
